Insights
Featured Topics
WFW advises Mirova on 250 MW Italian renewable portfolio JV with Qualitas7 April 2025
WFW advised Mirova on the establishment of a joint venture with Qualitas Energy to develop up to 250 MW of renewable projects in Italy.
WFW advises EQUITA Capital on acquisition of four PV projects28 February 2025
The acquisition is part of EGIF’s commitment to support the energy transition.
WFW advises on €2.5bn Sonnedix refinancing18 February 2025
WFW also advised on the due diligence process for its 1.1 GW portfolio of renewable energy assets.
WFW advises a German financial investor on acquisition of OMB Saleri19 December 2024
We advised a German financial investor on its acquisition of OMB Saleri S.p.A. – Società Benefit, an Italian company specialising in the production of high-tech valves and components for sustainable mobility.
WFW advises AEER on acquisition of three BESS projects6 November 2024
The projects will have a total combined capacity of approximately 310 MW.
WFW advises Azimut on JV with Veos26 September 2024
The corporate and contractual JV was set up as new company using an innovative structure.
WFW advises Verdalia on acquisition of four biomethane plants1 August 2024
The plants will have a total annual production capacity of approximately 230 GWh of biomethane.
WFW advises CMFL on novation of bareboat charter and purchase of drilling rig by Saipem21 March 2024
Sea Lion 7 is a self-elevating mobile drilling unit capable of operating in water depths of up to 114.3 metres.
WFW advises GreenGo on 120 MW BESS project acquisition13 March 2024
The project will have a total installed capacity of approximately 120 MW and 480 MWh of storable energy.
WFW advises GreenGo on €15m equity bridge financing from Eiffel2 August 2023
The financing will be used to develop a 40 MW portfolio of ready-to-build projects.
WFW advises Logista on Gramma Farmaceutici acquisition26 July 2023
Watson Farley & Williams advised Logista Italia S.p.A. on the acquisition of Gramma Farmaceutici, a provider of logistics services to the Italian pharmaceutical industry.
